AbbVie sues HHS over Botox Medicare pricing, challenging CMS authority under the Inflation Reduction Act and drug price negotiation rules.
AbbVie contends that Botox should have been excluded from the IRA drug price negotiation program because it is a ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers.
As the Centers for Medicare and Medicaid Services (CMS) hits reset on an important value-based care initiative popular with health care providers, ...
Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.
In the $1.2 trillion budget package signed Tuesday, a little-known healthcare provision was reauthorized that will allow ...
The Centers for Medicare & Medicaid Services announced a seven-prong update to the Civil Money Penalty Reinvestment Program on Monday. The agency has increased the project funding cap by 20% and also ...
CMS' first bundled payment model, Medicare saved $112.7M but saw no quality improvements in joint replacement care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results